The Illustris technology platform both enables the delivery of large molecules through tissue structures, and optimizes the absorption of compounds typically delivered through skin, hair, eyes, mucosal surfaces and even bone!



The Illustris family of technologies provides a significant competitive advantage with its novel approach to molecule delivery, yielding enhanced safety and efficacy for patients.

 Explore →


Illustris is a privately-held bio-development company redefining the delivery of active ingredients through tissue structures historically difficult or impossible to deliver topically. 

 Learn More →